Development of biotechnological drugs for use in cancer treatment by employing advanced technologies in world standards
Capabilities of Genetic Engineering and Biotechnology Institute:
- Development and production of Turkey’s first national biosimilar drug for cancer treatment as a result of a partnership between public R&D and private sector
- Development of biotechnological cells operating like a biological factory that produces biosimilar drugs and creation of a mother-cell bank and working cell lines
- Physicochemical and biological characterization of product
Usage Area:
Pharmaceutical Industry